Baltimore’s litigation against opioid companies has been wildly successful. Now comes the hard part of spending the money.

McKesson and AmerisourceBergen were found liable in Baltimore, ordered to pay over $266 million for their role in the opioid ...

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so ...

Jurors found that the companies, McKesson and AmerisourceBergen, unreasonably shipped huge sums of painkillers to the ...

Baltimore just won a $266 million verdict against drug distributors over the opioid crisis. The city reports more than 2 ...

Two pharmaceutical companies have been found liable in Baltimore's opioid epidemic. McKesson and AmerisourceBergen have been ...

AmerisourceBergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain.

Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment.

Jurors in Baltimore will decide if two drug companies should pay the city over $260 million in damages for allegedly contributing to its opioid crisis.

Baltimore’s remaining claims against opioid distributors McKesson and AmerisourceBergen appear slated to proceed to trial this week. Jury selection began Monday and it could take several days ...